HIV/AIDS

DermTech Names Daniel P. Kolk, Ph.D., as Vice President, Product Development

Published in Hepatitis Weekly, July 2nd, 2007

DermTech, a biotechnology company developing skin sampling technologies for the early detection of melanoma and other diseases, has named Daniel P. Kolk, Ph.D. to the position of Vice President, Product Development.

Dr. Kolk joins DermTech from Gen-Probe Inc. where for 12 years he was instrumental in the creation of multiple high-value molecular diagnostic products. Specifically, Dr. Kolk co-developed an assay that detects HIV-1 and HCV. That assay received FDA licensure in 2002 for use in blood screening and it is currently used to screen over 85% of all blood in the US for HIV-1 and HCV. He also co-developed the next generation version that included detection of HBV...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2007-07-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry